CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 30,357	$ 24,570
Short-term marketable securities	74,957	89,024
Accounts receivable, net	250	318
Prepaid expenses and other current assets	3,226	12,039
Total current assets	108,790	125,951
Marketable securities	85,211	90,302
Property and equipment, net	942	1,008
Other assets	3,151	3,066
Total assets	198,094	220,327
Current liabilities:
Accounts payable	6,354	4,690
Accrued expenses	8,572	20,333
Deferred income	3,888	3,890
Other current liabilities	2,700	2,683
Total current liabilities	21,514	31,596
Other liabilities	4,308	4,439
Deferred income, net of current portion	19,206	20,038
Contingent consideration	9,000	8,700
Total liabilities	54,028	64,773
Stockholders' Equity:
Preferred stock, $0.00001 par value; 10,000,000 shares authorized and no shares issued or outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.00001 par value; 200,000,000 shares authorized at March 31, 2025 and December 31, 2024; 108,265,529 and 107,850,124 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	1	1
Additional paidin capital	1,061,577	1,058,317
Accumulated other comprehensive income	434	97
Accumulated deficit	(917,946)	(902,861)
Total stockholders' equity	144,066	155,554
Total liabilities and stockholders' equity	$ 198,094	$ 220,327